The anti-calcitonin gene-related peptide (CGRP) monoclonal antibody erenumab is associated with rapid and sustained conversion from chronic to episodic migraine, new research suggests.
AbbVie to Present Data From Its Migraine Portfolio at the 2021 International Headache Congress prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
AbbVie to Present Data From Its Migraine Portfolio at the 2021 International Headache Congress investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.
ABBVie today announced data from its migraine portfolio will be presented at the 2021 American Headache Society Annual Scientific Meeting, to be held virtually June 3-6 . A total of 23 abstracts, including four podium presentations, will be shared from a broad range of studies across ABBVie's migraine portfolio. "Migraine is an often-debilitating disease that affects millions of people in the prime of their lives, .
Green Light May Put a Stop to Migraine medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.